Charles River Laboratories | CRL - Los Gastos De Explotación

Precio De Mercado
169.80
Cambio Diario
2.06 1.23%
Mensual
2.36%
Anual
48.09%
Q2 Expectativa
166.17




Los Gastos De Explotación Cambio Fecha
Agilent USD 1.44B 27M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Cardinal Health USD -2.88B 5M 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cigna USD 41.71B 92.12M 2025-12
Concord Medical Services Hldg CNY 345.26M 153.27M 2025-06
CVS Health USD 103.58B 3.66B 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 423M 1.06B 2025-12
Elevance Health USD 43.9B 5.26B 2026-03
Galapagos EUR 120.26M 7.43M 2025-12
Humana USD 33.32B 1.07B 2025-12
Illumina USD 903M 69M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Intrexon USD 61.56M 26.1M 2024-06
IQVIA Holdings USD 1.69B 4.47B 2025-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Lonza CHF 2.9B 184M 2025-06
McKesson USD 104.5B 2.85B 2025-12
Merck EUR 4.78B 669M 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Novartis USD 9.8B 61M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Revvity USD 626.22M 25.62M 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
United Therapeutics USD 804.8M 5.79B 2025-12
UnitedHealth USD 102.68B 7.27B 2026-03
Veradigm USD 188M 61.08M 2022-12
Waters USD 661.85M 1.67B 2025-12
West Pharmaceutical Services USD 2.99B 2.35B 2026-03